Loss of anti-tumor protein may cause resistance to certain cancer therapies
HERSHEY, Pa. — The absence of a protein that works to prevent tumor formation may explain why some patients are resistant to a common cancer therapy, according to Penn State College of Medicine researchers. They said that testing cancers for the presence of this protein may help clinicians identify patients who may be resistant to…